Measures · C16 in 2023 · Part C · HD2 Managing Chronic (Long Term) Conditions
Statin Therapy for Patients with Cardiovascular Disease
Chronic ConditionsHealth PlanMedication AdherenceSource: HEDIS
- What it measures
- This rating is based on the percent of plan members with heart disease who get the right type of cholesterol-lowering drugs. Health plans can help make sure their members are prescribed medications that are more effective for them.
- How it's calculated
- The percentage of males 21–75 years of age and females 40–75 years of age during the measurement year, who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) (denominator) and were dispensed at least one high or moderate-intensity statin medication during the measurement year (numerator).
- Data source
- HEDIS
- Measurement period
- 01/01/2021 – 12/31/2021
- Better when
- Higher
- Weight
- 1 (Process Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- No
- In improvement measure
- Yes
- Used in CAI
- Yes
- HEDIS label
- Statin Therapy for Patients with Cardiovascular Disease (SPC)
- Exclusions
Show
Exclude members who meet any of the following criteria: • Pregnancy (Pregnancy Value Set) during the measurement year or year prior to the measurement year. • In vitro fertilization (IVF Value Set) in the measurement year or year prior to the measurement year. • Dispensed at least one prescription for clomiphene (Table SPC-A) during the measurement year or the year prior to the measurement year. • ESRD (ESRD Value Set) during the measurement year or the year prior to the measurement year. • Cirrhosis (Cirrhosis Value Set) during the measurement year or the year prior to the measurement year. • Myalgia, myositis, myopathy, or rhabdomyolysis (Muscular Pain and Disease Value Set) during the measurement year. • Members 66 years of age and older as of December 31 of the measurement year who meet either of the following: – Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. – Living long-term in an institution any time during the measurement year as identified by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file to determine if a member had an LTI flag during the measurement year. • Members 66 years of age and older as of December 31 of the measurement year with frailty (Frailty Value Set) and advanced illness during the measurement year. To identify members with advanced illness, any of the following during the measurement year or the year prior to the measurement year (count services that occur over both years), meet criteria: – At least two outpatient visits (Outpatient Value Set), observation visits (Observation Value Set), ED visits (ED Value Set) or nonacute inpatient encounters (Nonacute Inpatient Value Set) on different dates of service, with an advanced illness diagnosis (Advanced Illness Value Set). Visit type need not be the same for the two visits. – At least one acute inpatient encounter (Acute Inpatient Value Set) with an advanced illness diagnosis (Advanced Illness Value Set). – A dispensed dementia medication (Dementia Medications List). Contracts whose enrollment was at least 500 but less than 1,000 as of the July 2021 enrollment report and having measure score reliability less than 0.7 are excluded. Contracts whose enrollment was less than 500 as of the July 2021 enrollment report are excluded from this measure.- Disaster policy
- Higher measure star (2022-2023) for contracts with 25% or more enrolled affected by 2021 disasters.
From the 2023 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts.
2023 star distribution
Not rated: Plan too new to be measured (126); Not enough data available (96); Plan too small to be measured (94); Plan not required to report measure (68); No data available (35); Benefit not offered by plan (3)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA | < 82 % | >= 82 % to < 86 % | >= 86 % to < 89 % | >= 89 % to < 93 % | >= 93 % |
| 2026 | MA | < 81 % | >= 81 % to < 85 % | >= 85 % to < 88 % | >= 88 % to < 91 % | >= 91 % |
| 2025 | MA | < 81 % | >= 81 % to < 85 % | >= 85 % to < 88 % | >= 88 % to < 92 % | >= 92 % |
| 2024 | MA | < 79 % | >= 79 % to < 84 % | >= 84 % to < 86 % | >= 86 % to < 90 % | >= 90 % |
| 2023 | MA | < 75 % | >= 75 % to < 81 % | >= 81 % to < 85 % | >= 85 % to < 89 % | >= 89 % |
| 2022 | MA | < 76 % | >= 76 % to < 81 % | >= 81 % to < 84 % | >= 84 % to < 89 % | >= 89 % |
| 2021 | MA | < 75% | >= 75% to < 79% | >= 79% to < 83% | >= 83% to < 87% | >= 87% |
| 2020 | MA | < 75% | ? 75% to < 79% | ? 79% to < 83% | ? 83% to < 87% | ? 87% |
| 2019 | MA | < 70% | ? 70% to < 76% | ? 76% to < 81% | ? 81% to < 85% | ? 85% |
Lowest-scoring contracts, 2023
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H9877 Virginia Premier | Sentara Health Care (SHC) | — | 58 | 1 | 0 | 27 | 0% |
| H5190 Wellcare | Centene Corporation | 0 | 68 | 1 | −3 | 17 | 0% |
| H2416 PrimeWest Health | PrimeWest Rural MN Health Care Access Initiative | 2,277 | 70 | 1 | −3 | 15 | 0% |
| H1189 CHRISTUS Health Advantage | CHRISTUS Health | 8,875 | 71 | 1 | 0 | 14 | 1% |
| H2563 Sentara Medicare | Sentara Health Care (SHC) | 875 | 72 | 1 | −3 | 13 | 1% |
| H5430 WellCare | Centene Corporation | — | 72 | 1 | −1 | 13 | 1% |
| H2056 Aetna Medicare | CVS Health Corporation | 8,275 | 73 | 1 | — | 12 | 1% |
| H6743 ATRIO Health Plans | ATRIO Health Plans | 21,042 | 73 | 1 | 0 | 12 | 1% |
| R3175 UnitedHealthcare | UnitedHealth Group, Inc. | 0 | 73 | 1 | −1 | 12 | 1% |
| H6158 Arkansas Blue Medicare | USAble Mutual Insurance Company | 4,842 | 74 | 1 | — | 11 | 2% |
| H4213 Arkansas Blue Medicare | USAble Mutual Insurance Company | 2,258 | 75 | 2 | 0 | 10 | 2% |
| R5941 Anthem Blue Cross and Blue Shield | Elevance Health, Inc. | 13,077 | 75 | 2 | 0 | 10 | 2% |
| H5435 UnitedHealthcare | UnitedHealth Group, Inc. | 1,420 | 75 | 2 | 0 | 10 | 2% |
| H3464 UnitedHealthcare | UnitedHealth Group, Inc. | — | 76 | 2 | −1 | 9 | 3% |
| H3979 Blue Cross and Blue Shield of Oklahoma | Health Care Service Corporation | 3,163 | 76 | 2 | 0 | 9 | 3% |
| H4140 Doctors HealthCare Plans, Inc. | DOCTORS HEALTHCARE PLANS, INC. | 27,878 | 76 | 2 | −1 | 9 | 3% |
| H8597 Aetna Medicare | CVS Health Corporation | 13,523 | 76 | 2 | +1 | 9 | 3% |
| H3810 AllCare Advantage | AllCare Health, Inc. | 2,485 | 76 | 2 | −2 | 9 | 3% |
| H1365 Martin's Point Generations Advantage | Martin's Point Health Care, Inc. | 3,611 | 77 | 2 | −3 | 8 | 4% |
| H3206 Presbyterian Insurance Company, Inc. | Presbyterian Healthcare Services | — | 77 | 2 | 0 | 8 | 4% |
| H0302 Blue Cross Blue Shield of Arizona (AZ Blue) | Blue Cross Blue Shield of Arizona | 38,702 | 78 | 2 | 0 | 7 | 4% |
| H9630 Wellcare | Centene Corporation | 20,115 | 78 | 2 | +1 | 7 | 4% |
| H5590 Wellcare | Centene Corporation | 26,580 | 78 | 2 | 0 | 7 | 4% |
| H8711 Wellcare | Centene Corporation | 0 | 78 | 2 | — | 7 | 4% |
| H7020 HealthSpring | Health Care Service Corporation | 15,661 | 78 | 2 | 0 | 7 | 4% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | C18 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2025 – 12/31/2025 | 1 | HEDIS |
| 2026 | C19 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2024 – 12/31/2024 | 1 | HEDIS |
| 2025 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2023 – 12/31/2023 | 1 | HEDIS |
| 2024 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2022 – 12/31/2022 | 1 | HEDIS |
| 2023 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2021 – 12/31/2021 | 1 | HEDIS |
| 2022 | C16 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2020 – 12/31/2020 | 1 | HEDIS |
| 2021 | C20 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2020 | C21 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2019 | C22 | Statin Therapy for Patients with Cardiovascular Disease | 01/01/2017 – 12/31/2017 | 1 | HEDIS |